LOC255130 inhibitors belong to a specialized chemical class designed to selectively target and modulate the function of the non-coding RNA LOC255130. As a member of the extensive family of non-coding RNAs, LOC255130 falls under the category of long intergenic non-protein coding RNAs (lincRNAs). These non-coding RNAs, though devoid of protein-coding capacity, play crucial roles in regulating diverse cellular processes. The inhibitors developed for LOC255130 are intricately designed to interact with the unique molecular structure of this non-coding RNA, with the primary goal of disrupting its normal interactions within the cellular milieu and potentially influencing various cellular regulatory networks.
The molecular architecture of LOC255130 inhibitors is precisely tailored to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. This interaction holds the potential to impact the regulatory functions that LOC255130 may exert in cellular processes. In laboratory research, these inhibitors serve as essential tools, enabling scientists to probe the nuanced functions of LOC255130 in various cellular contexts. By manipulating the function of LOC255130, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC255130 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This compound inhibits RNA polymerase II, which could decrease the transcription of antisense RNAs like IGFBP7-AS1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, potentially reducing the expression of both coding and non-coding RNAs. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An environmental compound that can disrupt epigenetic regulation, potentially affecting RNA expression patterns. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known for intercalating into DNA and RNA, which might affect RNA stability and transcription. | ||||||
Acriflavine | 8048-52-0 | sc-214489 sc-214489A | 25 g 100 g | $50.00 $171.00 | 2 | |
Intercalates with DNA and could inhibit the transcription of various RNA species. | ||||||
Ethidium bromide | 1239-45-8 | sc-203735 sc-203735A sc-203735B sc-203735C | 1 g 5 g 25 g 100 g | $48.00 $150.00 $588.00 $2086.00 | 12 | |
Another intercalating agent that can inhibit nucleic acid synthesis and potentially decrease RNA expression. | ||||||
Daunorubicin hydrochloride | 23541-50-6 | sc-200921 sc-200921A sc-200921B sc-200921C | 10 mg 50 mg 250 mg 1 g | $105.00 $438.00 $837.00 $1569.00 | 4 | |
Inhibits both DNA and RNA synthesis, which could lead to decreased expression of antisense RNAs. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Alkylates DNA and can inhibit RNA synthesis; thus, it may decrease the expression of IGFBP7-AS1. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I and can lead to reduced transcription of long non-coding RNAs. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Another DNA intercalator that inhibits nucleic acid synthesis, potentially affecting the expression of antisense RNAs. | ||||||